Taking Leqembi Isn’t Enough: Only 3% of Early Alzheimer’s Patients Follow Recommended Lifestyle Habits
The arrival of disease-modifying treatments capable of slowing Alzheimer’s progression has offered patients newfound hope.
Search results for "new dementia drug"
New Blood Test Accurately Predicts Alzheimer’s Progression, Pinpointing Optimal Candidates for Treatment
Dementia medications do not yield uniform results for every patient; instead, their clinical efficacy depends heavily on a distinct "optimal...
Can 'Sound and Light' Treat the Brain? New Hope for Dementia Therapy Without Side Effects
A South Korean research team has demonstrated the potential for treating Alzheimer’s disease using non-invasive sound...
“65% of Dementia-Causing Protein Removed Without Drugs” Could Ultrasound Offer New Hope?
A South Korean research team has succeeded in removing a key substance implicated in Alzheimer’s disease using...
"65% Reduction of Dementia-Causing Protein Without Drugs" Ultrasound, A New Hope?
A domestic research team has succeeded in removing the causative substances of Alzheimer's disease using ultrasound.
'2 Million Brain Cells Die Every Minute': Neurologists Call for National Strategy as South Korea Ages
"In a super-aged society, brain diseases represent a core healthcare challenge that the nation must tackle...
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements
The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight
For decades, Alzheimer’s disease research has focused intensely on two primary culprits: beta-amyloid, which forms...
GemVax’s GV1001 Activates Brain’s 'Cleanup Cells' to Clear Alzheimer’s Plaques
GemVax & Kael announced on June 10 that a study detailing the therapeutic mechanism of its Alzheimer’s disease drug...
K-Pharma Sets Sights on Veterinary Market: Daewoong Pharmaceutical Leads the Charge
More than 10 South Korean pharmaceutical companies are pivoting toward veterinary medicine as a strategic growth engine.